ICU Medical (ICUI) — Stock, Pipeline & Market Cap

Is this your company? Claim your profile to update info and connect with investors.

Private Company

Total funding raised: $200M

Market Cap: $3.3BFounded: 1984HQ: San Clemente, United States

Sector Ranking#30 in Drug Delivery & Formulation

Overview

ICU Medical is a mission-driven, global medical device company focused on enhancing patient safety and clinician workflow through integrated hardware, software, and consumable solutions. Its strategic achievements include the 2025 launch of its next-generation IV Performance Platform and the completion of a major joint venture with Otsuka Pharmaceutical Factory to bolster IV solutions manufacturing. The company's strategy centers on building interoperable ecosystems, expanding its digital health offerings, and leveraging its diversified portfolio to address critical care needs across the healthcare continuum.

Critical CareInfusion TherapyRespiratory CareRenal CarePain Management

Technology Platform

Integrated ecosystems combining hardware, software, and disposables, centered on the IV Performance Platform for interoperable infusion therapy and extending to digital health applications and pharmacy automation.

Funding History

2

Total raised:$200M

Debt$200MUndisclosedJan 15, 2017

IPOUndisclosedUndisclosedJun 15, 1992

Opportunities

Significant growth is driven by the global shift towards interoperable, smart medical devices and hospital pharmacy automation.

The recent launch of the IV Performance Platform positions the company to capture market share in the evolving infusion therapy segment, while expansion into digital health and post-acute care presents new avenues for growth.

Risk Factors

Key risks include execution challenges in commercializing the new IV platform against entrenched competitors, operational and integration risks from the Otsuka joint venture, and ongoing regulatory and pricing pressures inherent in the global medical device industry.

Competitive Landscape

ICU Medical faces intense competition across segments: against BD and B. Braun in infusion pumps, BD and Equashield in pharmacy safety devices, and Medtronic and Teleflex in airway management. Its competitive edge lies in its integrated portfolio, focus on interoperability, and strategic manufacturing partnership.